Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-01-08 21:07:50
Reporting Period:
Filing Date:
Accepted Time:
2015-01-08 21:07:50
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218105 Jr R William Shanahan C/o Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego CA 92121
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-07 50,000 $1.49 100,000 No 4 M Direct
Common Stock Disposition 2015-01-07 50,000 $5.49 50,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-07 50,000 $0.00 50,000 $1.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,000 2021-03-15 No 4 M Direct
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The options vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 15, 2012, 2013 and 2014, respectively, and the fourth installment vests on March 15, 2015.